BRCA1/2, PALB2 mutations and first-line CDK4/6 inhibitor efficacy in HR+ metastatic breast cancer
BRCA1/2、PALB2 突变与 HR+ 转移性乳腺癌一线 CDK4/6 抑制剂疗效
期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2026.104739
Guinel, Timothé; Lusque, Amélie; Mailliez, Audrey; Massard, Vincent; Jacot, William; Guiu, Severine; de la Motte Rouge, Thibault; Brain, Etienne; Desmoulins, Isabelle; Arnedos, Monica; Bailleux, Caroline; Goncalves, Anthony; Levy, Christelle; Bachelot, Thomas; Bosquet, Lise; Delaloge, Suzette; Frénel, Jean-Sébastien